METROPOLIS

Metropolis Healthcare Limited · NSE · INE112L01020 · 272 sessions on record

₹537.90▼ −3.80 · −0.7%from ₹541.70 the session before · 1 Oct 2026 close · NSE end of day

Open: ₹537.95
High: ₹549.00
Low: ₹526.30
Day's range: ₹234.2% of the previous close
VWAP: ₹540.09close −0.40% from it
Volume, shares: 4.5 L2.04× the 20-session average
Turnover, ₹ crore: 24
Trades: 26,00017 shares per trade
Previous close: ₹541.70−3.80 to the close
Price band, next session: ₹484.10 – ₹591.7010% either side of the close · dynamic, widened in 5% steps when hit

Day range51% of the way up

₹526.30₹549.00

52-week range7% of the way up

₹412.25 2 Apr₹2,160.00 7 Oct

−75% from the high · +30% from the low

Futures and options

No derivatives listed on METROPOLIS

Close ₹ · Nifty 50 rebased to the first close · futures open interest by the day's build-up126 sessions to 1 Oct · axis fixed at 4 × ATR-14 around the last close · hover or tap a session and the read beside the chart follows it

272 sessions on file · from 28 Aug

METROPOLIS close
Nifty 50, rebased

Session read · latest close: 1 Oct 2026
Close ₹ · day %: ₹537.90▼ −0.7% on the previous close
Against Nifty 50: Nifty −0.9%+0.2 pp difference on the day
Against the averages: below 20 · below 5020-session ₹580.60 (−7.4%) · 50-session ₹574.41 (−6.4%)
Volume: 2.04×the previous 20 sessions · 4.5 L shares
Extremes on the day: none

The market after the news

close against the last close before each bulletin · Nifty 50 over the same sessions

After the last 3 bulletins, METROPOLIS closed higher five sessions later in 1 of 3.

Close after each bulletin on the day, one session later and five sessions later, with Nifty 50 and futures open interest
Bulletin	Day of the news	1 session later	5 sessions later	Futures OI on the day
14 MayMetropolis Healthcare Q4 profit doubles on revenue growth	▼ −1.3%Nifty +1.2% · −2.5 pp	▼ −3.5%Nifty +1.0% · −4.5 pp	▼ −3.5%Nifty +1.0% · −4.5 pp	—
11 MarHealthcare stock rises on 3:1 bonus issue announcement	▼ −0.7%Nifty −0.9% · +0.2 pp	▼ −1.6%Nifty −3.0% · +1.4 pp	▼ −0.7%Nifty −3.6% · +2.9 pp	—
5 FebMetropolis Healthcare Q3 net profit rises 32%, bonus issue declared	▲ +4.0%Nifty −0.5% · +4.5 pp	▲ +4.8%Nifty −0.3% · +5.1 pp	▲ +4.8%Nifty +0.1% · +4.7 pp	—

3 of 3 bulletins

Quarterly results

consolidated · latest filed 4 Aug, 07:15 pm IST · NSE filings

Revenue ₹450 cr; profit ₹57 cr in the Jun 2026 quarter, consolidated.

Last 2 quarters, consolidated₹ crore as filed · year on year against the same quarter a year earlier · market: close on the first session after the filing against the last close before it, Nifty 50 over the same session

Quarterly results of METROPOLIS on the consolidated basis with the market's move on the first session after each filing
Quarter	Revenue ₹ cr	Revenue YoY	Profit ₹ cr	Profit YoY	EPS ₹	Market on the day
Jun 2026filed 4 Aug	₹450 cr	—	₹57 cr	—	2.73	▼ −1.3%Nifty 0.0% · −1.4 pp
Mar 2026filed 13 May · audited	₹425 cr	—	₹51 cr	—	2.46	▼ −1.3%Nifty +1.2% · −2.5 pp

Fundamentals

consolidated · filings to Jun 2026 · close ₹537.90 on 1 Oct

7.3 times book value, a 0.93% dividend yield, market cap ₹11,000 cr.

Valuationarithmetic on filings and the close · each cell names what it rests on · — where an input is missing

Market cap: ₹11,000 cron 1 Oct · free float ₹5,700 cr
Price to earnings: —fewer than four consecutive quarters filed
Trailing EPS: —fewer than four consecutive quarters filed
Price to book: 7.3consolidated · balance sheet to Mar 2026
Book value a share: ₹73.51consolidated · balance sheet to Mar 2026 · over NSE's share count
Debt to equity: 0.01borrowings over equity · consolidated · balance sheet to Mar 2026
Return on equity: —needs two filed balance sheets
Dividend yield: 0.93%₹5.00 a share in 365 days
Face value: ₹2a share
Shares outstanding: 21 cron 1 Oct

Growthsums of the four quarters filed to Jun 2026 · growth against the four quarters before them · consolidated

Revenue, trailing 12 months: —fewer than four consecutive quarters filed
Revenue growth, 12 months: —needs eight consecutive quarters filed
Revenue 3-year CAGR: —needs twelve consecutive quarters filed
Profit, trailing 12 months: —fewer than four consecutive quarters filed
Profit growth, 12 months: —needs eight consecutive quarters filed
Profit 3-year CAGR: —needs twelve consecutive quarters filed

PeersBSE sub-group Healthcare Service Provider · F&O stocks with filings on record · industry P/E needs two stocks with trailing profit and a market cap

Stocks in the BSE sub-group Healthcare Service Provider with market cap, price to earnings and price to book
Stock	Market cap ₹	P/E	P/B	Close ₹
LALPATHLABDr. Lal Path Labs Ltd.	34,000 cron 1 Oct	—	13	₹2,005.10
VIJAYAVijaya Diagnostic Centre Limited	15,000 cron 1 Oct	—	15	₹1,428.00
METROPOLISMetropolis Healthcare Limited	11,000 cron 1 Oct	—	7.3	₹537.90
THYROCAREThyrocare Technologies Limited	8,500 cron 1 Oct	—	14	₹533.60
NEPHROPLUSNephrocare Health Services Limited	6,500 cron 1 Oct	—	5.8	₹648.95
SURAKSHASuraksha Diagnostic Limited	1,800 cron 1 Oct	—	7.5	₹350.15
KRSNAAKrsnaa Diagnostics Limited	1,800 cron 1 Oct	—	1.8	₹554.85
3BBLACKBIO3B Blackbio Dx Limited	1,400 cron 1 Oct	—	—	₹1,646.80
ONEGLOBALOne Global Service Provider Limited	1,000 cron 1 Oct	—	—	₹525.40
HEALTHXHealth X Platform Limited	870 cron 1 Oct	—	1.1	₹273.00
GAUDIUMIVFGaudium IVF and Women Health Limited	800 cron 1 Oct	—	5.2	₹109.50

Shareholding

quarter to 30 Jun · 1.2% of the promoter holding pledged · NSE filings

Promoters hold 48.9%, foreign portfolio investors 11.0%, mutual funds 32.7% and insurance companies 2.1%, as filed for the quarter to 30 Jun.

48.9%11.0%32.7%

By category, last 3 quarterspercent of shares · beneath each figure, the change in percentage points against the previous quarter on file

Shareholding of METROPOLIS by category over the last 3 quarters with the change against the previous quarter
Category	30 Jun	31 Mar	23 Mar
Promoters	48.86▼ −0.01 pp	48.870.00 pp	48.87
Foreign portfolio investors	11.03▲ +0.60 pp	10.43▼ −0.34 pp	10.77
Mutual funds	32.67▼ −0.61 pp	33.28▲ +0.35 pp	32.93
Insurance companies	2.06▼ −0.10 pp	2.16▼ −0.01 pp	2.17
Banks and financial institutions	0.39▲ +0.03 pp	0.360.00 pp	0.36
Individual investors	4.34▲ +0.05 pp	4.29▼ −0.03 pp	4.32
Bodies corporate	0.30▲ +0.11 pp	0.19▲ +0.01 pp	0.18
Others	0.36▼ −0.08 pp	0.44▲ +0.03 pp	0.41

Corporate actions

NSE and BSE records

Nothing upcoming on record; the last was a dividend of ₹1.00 a share, ex-date 19 May 2026.

Actionsex-dates · upcoming first, then the last eight · dividends in rupees a share, bonus and split as ratios

Corporate actions of METROPOLIS, upcoming first, then the most recent
Ex-date	Action	Amount or ratio	Record date	Source
recent
19 May 2026	dividend	₹1.00	19 May 2026	NSE
20 Mar 2026	bonus	3:1	20 Mar 2026	NSE
11 Nov 2025	dividend	₹4.00	11 Nov 2025	NSE

Calendaras notified to the exchange

Next results: —no board meeting notified yet
Dividends in 365 days: ₹5.00a share · ex-dates inside the year
Last dividend: ₹1.00ex-date 19 May 2026

Price history

272 sessions on record · to 1 Oct · NSE end of day

METROPOLIS is −7.6% over 20 sessions against Nifty's −6.2%, 75% below its 52-week high, realised volatility 27% annualised.

Returns against Nifty 50longest window first · Nifty 50 over the same sessions

Returns of the stock and Nifty 50 over six windows, longest first
Window	From ₹	METROPOLIS %	Nifty 50 %	Difference pp
250 sessionssince 26 Sept	₹2,014.61	▼ −73%	▼ −9.1%	−64
120 sessionssince 9 Apr	₹456.89	▲ +18%	▼ −5.7%	+23
60 sessionssince 8 Jul	₹549.33	▼ −2.1%	▼ −6.1%	+4.0
20 sessionssince 2 Sept	₹582.21	▼ −7.6%	▼ −6.2%	−1.4
5 sessionssince 24 Sept	₹582.96	▼ −7.7%	▼ −2.8%	−5.0
1 sessionsince 30 Sept	₹541.69	▼ −0.70%	▼ −0.88%	+0.18

Averages of the closeclose against each average

5-session average: ₹559.36close −3.8% from it
20-session average: ₹580.60close −7.4% from it
50-session average: ₹574.41close −6.4% from it
200-session average: ₹999.59close −46% from it

Range and volumetrue range over 14 sessions · high to low over 20 · volume against the 20-session average

Average true range, 14: ₹183.3% of the close
Average day's range, 20: ₹162.9% of the close
Volume against 20 sessions: 2.04×4.5 L vs 2.3 L average

Volatility and co-movement with Nifty 50annualised from daily log returns · counts share one denominator per cell

Realised volatility, 20: 27%≈ ±1.7% a session · moved more than that on 8 of 20
Realised volatility, 60: 29%≈ ±1.8% a session · moved more than that on 17 of 60
Realised volatility, 250: 150%≈ ±9.2% a session · moved more than that on 1 of 250
Beta to Nifty, 60: 0.36moved with Nifty on 33 of 60 sessions
Beta to Nifty, 250: 0.00moved with Nifty on 144 of 250 sessions

Up and down sessionscloses above and below the previous close

Last 20 sessions: 6 up · 14 downof 20
Last 60 sessions: 28 up · 32 downof 60
Last 250 sessions: 119 up · 131 downof 250
Best session, 250: ▲ +8.7%8 May
Worst session, 250: ▼ −76%20 Mar

Metropolis Healthcare Limited is in 4 NSE indices

3 bulletins on METROPOLIS

latest 14 May 2026

Beats in the coverage

Healthcare3

May 2026

14 May Metropolis Healthcare Q4 profit doubles on revenue growthMetropolis Healthcare reported a net profit of ₹51 crore for Q4, a 131.8% increase YoY. Revenue rose 23% to ₹425 crore, with EBITDA up 73.4% to ₹108 crore, leading to improved margins of 25.4%.High

March 2026

11 Mar Healthcare stock rises on 3:1 bonus issue announcementShares of Metropolis Healthcare Ltd increased nearly 2% after announcing March 20, 2026, as the record date for a 3:1 bonus issue. The company reported 9% growth in patient volumes and 8% increase in test volumes, indicating strong operational performance.Medium

February 2026

5 Feb Metropolis Healthcare Q3 net profit rises 32%, bonus issue declaredMetropolis Healthcare reported a 32% rise in Q3 net profit to ₹41.4 cr, with revenue up 25.8% to ₹406 cr. The company declared a 3:1 bonus issue, further boosting shareholder value.High

About Metropolis Healthcare Limited

exchange masters as of 18 Sept 2026 · classification by BSE

Company: Metropolis Healthcare Limited
Exchange: NSE · BSE 542650, group A
Listed on NSE: 15 Apr 2019
Classification: Healthcare › Healthcare Services › Healthcare Service Provider
Index: BSE 1000
Face value: ₹2 a share
ISIN: INE112L01020
Sessions on record: 272
Price source: NSE UDiFF bhavcopy · end of day · delayed
Filings: NSE and BSE public disclosures · results, shareholding and corporate actions as filed
Computed: 2 Oct, 02:30 am IST
Bulletins: 3 · written by the desk · not a recommendation

OI Charts is not a SEBI-registered investment adviser or research analyst. Prices, open interest, filings and the desk read are exchange data and arithmetic on it, not a basis for any investment decision.